{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:25:36Z","timestamp":1790360736310,"version":"4.1.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T00:00:00Z","timestamp":1564099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Chemicals Managment Plan, a Government of Canada initiative"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Hygiene and Environmental Health"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.ijheh.2019.07.009","type":"journal-article","created":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T00:36:55Z","timestamp":1568335015000},"page":"267-280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Evaluation of human biomonitoring data in a health risk based context: An updated analysis of population level data from the Canadian Health Measures Survey"],"prefix":"10.1016","volume":"223","author":[{"given":"Sarah","family":"Faure","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nolwenn","family":"Noisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Werry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subramanian","family":"Karthikeyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesa L.","family":"Aylward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"St-Amand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ijheh.2019.07.009_bib1","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ijheh.2011.06.002","article-title":"Human biomonitoring assessment values: approaches and data requirements","volume":"214","author":"Angerer","year":"2011","journal-title":"Int. J. Hyg Environ. Health"},{"issue":"2","key":"10.1016\/j.ijheh.2019.07.009_bib2","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijheh.2016.09.007","article-title":"New HBM values for emerging substances, inventory of reference and HBM values in force, and working principles of the German Human Biomonitoring Commission","volume":"220","author":"Apel","year":"2017","journal-title":"Int. J. Hyg Environ. Health"},{"issue":"2","key":"10.1016\/j.ijheh.2019.07.009_bib3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.yrtph.2014.12.013","article-title":"Derivation of human Biomonitoring Guidance Values for chlorpyrifos using a physiologically based pharmacokinetic and pharmacodynamic model of cholinesterase inhibition","volume":"71","author":"Arnold","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"6","key":"10.1016\/j.ijheh.2019.07.009_bib4","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ijheh.2016.05.005","article-title":"Biomonitoring Equivalents for interpretation of silver biomonitoring data in a risk assessment context","volume":"219","author":"Aylward","year":"2016","journal-title":"Int. J. Hyg Environ. Health"},{"issue":"3","key":"10.1016\/j.ijheh.2019.07.009_bib5","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.yrtph.2015.11.001","article-title":"Interpreting biomonitoring data for 2, 4-dichlorophenoxyacetic acid: update to Biomonitoring Equivalents and population biomonitoring data","volume":"73","author":"Aylward","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijheh.2019.07.009_bib6","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.yrtph.2015.04.005","article-title":"Biomonitoring Equivalents for interpretation of urinary fluoride","volume":"72","author":"Aylward","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.ijheh.2019.07.009_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.yrtph.2017.11.002","article-title":"Screening-level Biomonitoring Equivalents for tiered interpretation of urinary 3-phenoxybenzoic acid (3-PBA) in a risk assessment context","volume":"92","author":"Aylward","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"4","key":"10.1016\/j.ijheh.2019.07.009_bib8","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/jes.2012.35","article-title":"Interpreting variability in population biomonitoring data: role of elimination kinetics","volume":"22","author":"Aylward","year":"2012","journal-title":"J. Expo. Sci. Environ. Epidemiol."},{"issue":"1","key":"10.1016\/j.ijheh.2019.07.009_bib9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.yrtph.2010.05.011","article-title":"Chemical-specific screening criteria for interpretation of biomonitoring data for volatile organic compounds (VOCs)\u2013Application of steady-state PBPK model solutions","volume":"58","author":"Aylward","year":"2010","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"3","key":"10.1016\/j.ijheh.2019.07.009_bib10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1289\/ehp.1205740","article-title":"Evaluation of biomonitoring data from the CDC National Exposure Report in a risk assessment context: perspectives across chemicals","volume":"121","author":"Aylward","year":"2013","journal-title":"Environ. Health Perspect."},{"issue":"2","key":"10.1016\/j.ijheh.2019.07.009_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.yrtph.2011.03.014","article-title":"Biomonitoring equivalents for deltamethrin","volume":"60","author":"Aylward","year":"2011","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"3","key":"10.1016\/j.ijheh.2019.07.009_bib12","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1016\/j.yrtph.2008.05.005","article-title":"Biomonitoring Equivalents (BE) dossier for trihalomethanes","volume":"51","author":"Aylward","year":"2008","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.ijheh.2019.07.009_bib13","series-title":"Canadian Environmental Protection Act, 1999 (CEPA 1999). SC 1999, c. 33","author":"Canada","year":"1999"},{"key":"10.1016\/j.ijheh.2019.07.009_bib14","series-title":"Chemicals Management Plan","author":"Canada","year":"2006"},{"key":"10.1016\/j.ijheh.2019.07.009_bib15","series-title":"Pest Control Products Act. SC 2002, c. 28","author":"Canada","year":"2006"},{"key":"10.1016\/j.ijheh.2019.07.009_bib16","series-title":"Toxic Substances List: Schedule 1","author":"Canada","year":"2018"},{"issue":"1","key":"10.1016\/j.ijheh.2019.07.009_bib17","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.taap.2008.04.021","article-title":"Quantitative interpretation of human biomonitoring data","volume":"231","author":"Clewell","year":"2008","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ijheh.2019.07.009_bib18","series-title":"Chemicals Management Plan, Risk Management Actions to Address Risks from Substances Concluded to Be Harmful to the Environment And\/or Human Health as Per Section 64 of the Canadian Environmental Protection Act, 1999","author":"ECCC (Environment and Climate Change Canada)","year":"2016"},{"key":"10.1016\/j.ijheh.2019.07.009_bib19","series-title":"Assessment Report Triclosan Chemical Abstracts Service Registry Number 3380-34-5. Ottawa, ON, Canada","author":"ECCC and HC (Environment and Climate Change Canada and Health Canada)","year":"2016"},{"key":"10.1016\/j.ijheh.2019.07.009_bib20","series-title":"Identification of Risk Assessment Priorities (IRAP): Result of the 2017-18 Review. Ottawa, ON, Canada","author":"ECCC and HC (Environment and Climate Change Canada and Health Canada)","year":"2019"},{"key":"10.1016\/j.ijheh.2019.07.009_bib21","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.envint.2018.07.011","article-title":"Leveraging the Canadian health measures survey for environmental health research","volume":"119","author":"Eykelbosh","year":"2018","journal-title":"Environ. Int."},{"issue":"2","key":"10.1016\/j.ijheh.2019.07.009_bib22","first-page":"10","article-title":"Cadmium levels and sources of exposure among Canadian adults","volume":"27","author":"Garner","year":"2016","journal-title":"Health Rep."},{"issue":"1\u20133","key":"10.1016\/j.ijheh.2019.07.009_bib23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1504\/IJRAM.2017.082561","article-title":"The role of human biological monitoring in health risk assessment","volume":"20","author":"Gurusankar","year":"2017","journal-title":"Int. J. Risk Assess. Manag."},{"issue":"3","key":"10.1016\/j.ijheh.2019.07.009_bib24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/taap.1999.8803","article-title":"Physiological modeling of the toxicokinetic interactions in a quaternary mixture of aromatic hydrocarbons","volume":"161","author":"Haddad","year":"1999","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2","key":"10.1016\/j.ijheh.2019.07.009_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijheh.2016.08.002","article-title":"An overview of human biomonitoring of environmental chemicals in the Canadian Health Measures Survey: 2007\u20132019","volume":"220","author":"Haines","year":"2017","journal-title":"Int. J. Hyg Environ. Health"},{"issue":"3","key":"10.1016\/j.ijheh.2019.07.009_bib26","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/j.yrtph.2008.05.010","article-title":"Biomonitoring Equivalents (BE) dossier for acrylamide (AA) (CAS No. 79-06-1)","volume":"51","author":"Hays","year":"2008","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"4","key":"10.1016\/j.ijheh.2019.07.009_bib27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/jat.1410","article-title":"Using biomonitoring equivalents to interpret human biomonitoring data in a public health risk context","volume":"29","author":"Hays","year":"2009","journal-title":"J. Appl. Toxicol."},{"issue":"3","key":"10.1016\/j.ijheh.2019.07.009_bib28","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.yrtph.2009.09.002","article-title":"Derivation of biomonitoring equivalents for cyfluthrin","volume":"55","author":"Hays","year":"2009","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijheh.2019.07.009_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yrtph.2010.06.002","article-title":"Biomonitoring equivalents for inorganic arsenic","volume":"58","author":"Hays","year":"2010","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"3","key":"10.1016\/j.ijheh.2019.07.009_bib30","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.yrtph.2008.05.004","article-title":"Guidelines for the derivation of biomonitoring equivalents: report from the biomonitoring equivalents expert workshop","volume":"51","author":"Hays","year":"2008","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijheh.2019.07.009_bib31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.yrtph.2006.08.004","article-title":"Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective","volume":"47","author":"Hays","year":"2007","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.ijheh.2019.07.009_bib32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.yrtph.2016.03.004","article-title":"Biomonitoring equivalents for molybdenum","volume":"77","author":"Hays","year":"2016","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijheh.2019.07.009_bib33","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.yrtph.2014.07.017","article-title":"Biomonitoring equivalents for selenium","volume":"70","author":"Hays","year":"2014","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"3","key":"10.1016\/j.ijheh.2019.07.009_bib34","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.yrtph.2008.05.008","article-title":"Biomonitoring equivalents (BE) dossier for cadmium (Cd)(CAS No. 7440-43-9)","volume":"51","author":"Hays","year":"2008","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijheh.2019.07.009_bib35","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.yrtph.2011.12.001","article-title":"Biomonitoring equivalents for benzene","volume":"62","author":"Hays","year":"2012","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.ijheh.2019.07.009_bib36","series-title":"CEPA Supporting Documentation: Health-Based Tolerable Daily Intakes\/Concentrations and Tumorigenic Doses\/Concentrations for Priority Substances","author":"Health Canada","year":"1996"},{"key":"10.1016\/j.ijheh.2019.07.009_bib37","series-title":"Guidelines for Canadian Drinking Water Quality: Guideline Technical Document \u2013 Arsenic","author":"Health Canada","year":"2006"},{"key":"10.1016\/j.ijheh.2019.07.009_bib38","series-title":"Health Risk Assessment of Bisphenol A from Food Packaging Applications","author":"Health Canada","year":"2008"},{"key":"10.1016\/j.ijheh.2019.07.009_bib39","series-title":"Federal Contaminated Site Risk Assessment in Canada, Part I: 456 Guidance on Human Health Preliminary Quantitative Risk Assessment (PQRA), 457 Version 2.0","author":"Health Canada","year":"2010"},{"key":"10.1016\/j.ijheh.2019.07.009_bib40","series-title":"Guidelines for Canadian Drinking Water Quality: Guideline Technical Document\u2014Fluoride","author":"Health Canada","year":"2010"},{"key":"10.1016\/j.ijheh.2019.07.009_bib41","series-title":"Report on Human Biomonitoring of Environmental Chemicals in Canada","author":"Health Canada","year":"2010"},{"key":"10.1016\/j.ijheh.2019.07.009_bib42","series-title":"Residential Indoor Air Quality Guideline: Toluene","author":"Health Canada","year":"2011"},{"key":"10.1016\/j.ijheh.2019.07.009_bib43","series-title":"Health Canada Revised Exposure Assessment of Acrylamide in Food","author":"Health Canada","year":"2012"},{"key":"10.1016\/j.ijheh.2019.07.009_bib44","series-title":"Second Report on Human Biomonitoring of Environmental Chemicals in Canada","author":"Health Canada","year":"2013"},{"key":"10.1016\/j.ijheh.2019.07.009_bib45","series-title":"Guidelines for Canadian Drinking Water Quality: Guideline Technical Document \u2013 Toluene, Ethylbenzene and the Xylenes","author":"Health Canada","year":"2014"},{"key":"10.1016\/j.ijheh.2019.07.009_bib46","series-title":"Proposed Re-evaluation Decision PRVD2015-07, Deltamethrin. Pest Management Regulatory Agency (PMRA) Health Canada","author":"Health Canada","year":"2015"},{"key":"10.1016\/j.ijheh.2019.07.009_bib47","series-title":"Third Report on Human Biomonitoring of Environmental Chemicals in Canada","author":"Health Canada","year":"2015"},{"key":"10.1016\/j.ijheh.2019.07.009_bib48","series-title":"Science Approach Document Biomonitoring-Based Approach 2 for Barium-Containing Substances, Molybdenum-Containing Substances, Silver-Containing Substances, Thallium-Containing Substances, Inorganic Tin-Containing Substances","author":"Health Canada","year":"2016"},{"key":"10.1016\/j.ijheh.2019.07.009_bib49","series-title":"Acrylamide and Food","author":"Health Canada","year":"2017"},{"key":"10.1016\/j.ijheh.2019.07.009_bib50","series-title":"Arsenic","author":"Health Canada","year":"2017"},{"key":"10.1016\/j.ijheh.2019.07.009_bib51","series-title":"Fourth Report on Human Biomonitoring of Environmental Chemicals in Canada","author":"Health Canada","year":"2017"},{"key":"10.1016\/j.ijheh.2019.07.009_bib52","series-title":"Guidelines for Canadian Drinking Water Quality - Summary Table","author":"Health Canada","year":"2017"},{"key":"10.1016\/j.ijheh.2019.07.009_bib53","series-title":"Proposal to Update the Maximum Levels for Arsenic in Apple Juice and Water in Sealed Containers in the List of Contaminants and Other Adulterating Substances in Foods","author":"Health Canada","year":"2017"},{"key":"10.1016\/j.ijheh.2019.07.009_bib54","series-title":"Proposed Re-evaluation Decision PRVD2017-03, Lambda-Cyhalothrin. Pest Management Regulatory Agency (PMRA) Health Canada","author":"Health Canada","year":"2017"},{"key":"10.1016\/j.ijheh.2019.07.009_bib55","series-title":"Registration Decision RD2017-01, Beta-Cyfluthrin. Pest Management Regulatory Agency (PMRA) Health Canada","author":"Health Canada","year":"2017"},{"key":"10.1016\/j.ijheh.2019.07.009_bib56","series-title":"Guideline for Canadian Drinking Water Quality : Guideline Technical Document- Perfluorooctane Sulfonate (PFOS)","author":"Health Canada","year":"2018"},{"key":"10.1016\/j.ijheh.2019.07.009_bib57","series-title":"Guideline for Canadian Drinking Water Quality: Guideline Technical Document- Perfluorooctanoic Acid (PFOA)","author":"Health Canada","year":"2018"},{"key":"10.1016\/j.ijheh.2019.07.009_bib58","series-title":"Health Risk Assessment of Dietary Exposure to Cadmium","author":"Health Canada","year":"2018"},{"key":"10.1016\/j.ijheh.2019.07.009_bib59","series-title":"Re-evaluation Decision RVD2018-22, Cypermethrin and its Associated End-Use Products","author":"Health Canada","year":"2018"},{"key":"10.1016\/j.ijheh.2019.07.009_bib60","series-title":"Uses of Human Biomonitoring Data in Risk Assessment","author":"Health Canada","year":"2018"},{"key":"10.1016\/j.ijheh.2019.07.009_bib61","author":"Institute of Medicine (IOM)","year":"2000"},{"key":"10.1016\/j.ijheh.2019.07.009_bib62","series-title":"Safety Evaluation of Certain Contaminants in Food: Prepared by the Seventy-Second Meeting of the Joint FAO\/WHO Expert Committee on Food Additives (JECFA)","author":"JECFA (Joint, F. A. O., WHO Expert Committee on Food Additives, & World Health Organization)","year":"2011"},{"issue":"1","key":"10.1016\/j.ijheh.2019.07.009_bib63","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/jes.2011.37","article-title":"Evaluation of NHANES biomonitoring data for volatile organic chemicals in blood: application of chemical-specific screening criteria","volume":"22","author":"Kirman","year":"2012","journal-title":"J. Expo. Sci. Environ. Epidemiol."},{"issue":"1","key":"10.1016\/j.ijheh.2019.07.009_bib64","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.yrtph.2010.06.005","article-title":"Biomonitoring equivalents for bisphenol A (BPA)","volume":"58","author":"Krishnan","year":"2010","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijheh.2019.07.009_bib65","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.yrtph.2010.06.004","article-title":"Biomonitoring equivalents for triclosan","volume":"58","author":"Krishnan","year":"2010","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"3","key":"10.1016\/j.ijheh.2019.07.009_bib66","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.yrtph.2008.05.007","article-title":"Guidelines for the communication of biomonitoring equivalents: report from the biomonitoring equivalents expert workshop","volume":"51","author":"LaKind","year":"2008","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"3","key":"10.1016\/j.ijheh.2019.07.009_bib67","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.yrtph.2014.05.008","article-title":"A new method for generating distributions of biomonitoring equivalents to support exposure assessment and prioritization","volume":"69","author":"Phillips","year":"2014","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijheh.2019.07.009_bib68","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1511\/2004.45.921","article-title":"Human Biomonitoring of Environmental Chemicals: measuring chemicals in human tissues is the \"gold standard\" for assessing people's exposure to pollution","volume":"92","author":"Sexton","year":"2004","journal-title":"Am. Sci."},{"issue":"1","key":"10.1016\/j.ijheh.2019.07.009_bib69","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijheh.2011.06.007","article-title":"Update of the reference and HBM values derived by the German human biomonitoring commission","volume":"215","author":"Schulz","year":"2011","journal-title":"Int. J. Hyg Environ. Health"},{"issue":"2","key":"10.1016\/j.ijheh.2019.07.009_bib70","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.toxlet.2014.10.019","article-title":"Screening of population level biomonitoring data from the Canadian Health Measures Survey in a risk-based context","volume":"231","author":"St-Amand","year":"2014","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ijheh.2019.07.009_bib71","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/14622200210123581","article-title":"Biochemical verification of tobacco use and cessation","volume":"4","author":"SRNT (Subcommittee on Biochemical Verification)","year":"2002","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.ijheh.2019.07.009_bib72","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.envres.2018.02.041","article-title":"Biomarkers of exposure in environment-wide association studies\u2013Opportunities to decode the exposome using human biomonitoring data","volume":"164","author":"Steckling","year":"2018","journal-title":"Environ. Res."},{"key":"10.1016\/j.ijheh.2019.07.009_bib73","series-title":"Cadmium (CASRN 7440-43-9)","author":"US EPA (United States Environmental Protection Agency)","year":"1989"},{"key":"10.1016\/j.ijheh.2019.07.009_bib74","series-title":"Arsenic, Inorganic (CASRN 7440-38-2). Integrated Risk Information System","author":"US EPA (United States Environmental Protection Agency)","year":"1991"},{"key":"10.1016\/j.ijheh.2019.07.009_bib75","series-title":"Silver (CASRN 7440-22-4). Integrated Risk Information System","author":"US EPA (United States Environmental Protection Agency)","year":"1991"},{"key":"10.1016\/j.ijheh.2019.07.009_bib76","series-title":"Styrene (CASRN 100-42-5)","author":"US EPA (United States Environmental Protection Agency)","year":"1992"},{"key":"10.1016\/j.ijheh.2019.07.009_bib77","series-title":"Benzene (CASRN 71-43-2). Integrated Risk Information System","author":"US EPA (United States Environmental Protection Agency)","year":"2000"},{"key":"10.1016\/j.ijheh.2019.07.009_bib78","series-title":"Chloroform (CASRN 67-66-3). Integrated Risk Information System","author":"US EPA (United States Environmental Protection Agency)","year":"2001"},{"key":"10.1016\/j.ijheh.2019.07.009_bib79","series-title":"Benzene (CASRN 71-43-2). Integrated Risk Information System","author":"US EPA (United States Environmental Protection Agency)","year":"2003"},{"key":"10.1016\/j.ijheh.2019.07.009_bib80","series-title":"Provisional Peer-Reviewed Toxicity Values for Bromoform","author":"US EPA (United States Environmental Protection Agency)","year":"2005"},{"key":"10.1016\/j.ijheh.2019.07.009_bib81","series-title":"Support of Summary Information on the Integrated Risk Information System","article-title":"Toxicological review of acrylamide (CASRN 79-06-1)","author":"US EPA (United States Environmental Protection Agency)","year":"2010"},{"key":"10.1016\/j.ijheh.2019.07.009_bib82","series-title":"Memorandum: 2,4-D Human Health Risk Assessment for Registration Review","author":"US EPA (United States Environmental Protection Agency)","year":"2016"},{"issue":"2","key":"10.1016\/j.ijheh.2019.07.009_bib83","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijheh.2016.10.007","article-title":"A review of human biomonitoring data used in regulatory risk assessment under Canada's Chemicals Management Program","volume":"220","author":"Zidek","year":"2017","journal-title":"Int. J. Hyg Environ. Health"}],"container-title":["International Journal of Hygiene and Environmental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1438463919304626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1438463919304626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T17:28:28Z","timestamp":1761413308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1438463919304626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":83,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S1438463919304626"],"URL":"https:\/\/doi.org\/10.1016\/j.ijheh.2019.07.009","relation":{},"ISSN":["1438-4639"],"issn-type":[{"value":"1438-4639","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of human biomonitoring data in a health risk based context: An updated analysis of population level data from the Canadian Health Measures Survey","name":"articletitle","label":"Article Title"},{"value":"International Journal of Hygiene and Environmental Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijheh.2019.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2019 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}]}}